Daniel Gerritzen compensation by year
ORTHOPEDIATRICS Summary Compensation Table · all 10 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salary | $210,000 | $216,000 | $230,000 | $287,000 | $300,000 | $300,000 | $330,000 | $353,100 | $368,000 | $368,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $94,500 | $126,680 | $105,900 | $374,183 | $328,021 | $292,175 | $548,640 | $813,909 | $1,040,050 | $972,427 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $93,135 | $104,328 | $105,721 | $130,596 | $88,500 | $131,067 | $128,239 | $171,695 | $179,755 | $143,757 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $8,400 | $11,400 | $11,500 | $12,200 | $13,200 | $12,153 | $12,880 |
| Total | $397,635 | $447,008 | $441,621 | $800,179 | $727,921 | $734,742 | $1,019,079 | $1,351,904 | $1,599,958 | $1,497,064 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ORTHOPEDIATRICS CORP DEF 14A filed April 20, 2026, accession 0001425450-26-000027, and prior-year filings.
How this page was built: the ORTHOPEDIATRICS CORP filed document, accession 0001425450-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 368,000 | $6,561,440 | — |
| RSU | 184,000 | $3,280,720 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in ORTHOPEDIATRICS CORP's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 20, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-13 | Gift | — | 2,479 | $0.00 | 147,054 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
ORTHOPEDIATRICS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Bailey | President and Chief Executive Officer | $3,331,481 |
| Fred Hite | Chief Operating Officer and Chief Financial Officer | $2,397,186 |
| Joseph Hauser | President of Trauma, Deformity and OPSB | $1,974,862 |
| Gregory Odle | President of Scoliosis | $1,498,184 |
| Daniel Gerritzen · this page | Executive Vice President (Legal), General Counsel, and Secretary | $1,497,064 |
Daniel Gerritzen's compensation dossier, ORTHOPEDIATRICS
You have read Daniel Gerritzen's totals and holdings. The dossier adds each equity grant ORTHOPEDIATRICS disclosed for Daniel Gerritzen and ORTHOPEDIATRICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full ORTHOPEDIATRICS compensation record
free company briefThis page is one person within ORTHOPEDIATRICS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ORTHOPEDIATRICS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ORTHOPEDIATRICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.